These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 3104464)

  • 41. Loss of the tumorigenic phenotype with in vitro, but not in vivo, passaging of a novel series of human bronchial epithelial cell lines: possible role of an alpha 5/beta 1-integrin-fibronectin interaction.
    Schiller JH; Bittner G
    Cancer Res; 1995 Dec; 55(24):6215-21. PubMed ID: 8521416
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Human recombinant macrophage inflammatory protein-1 alpha and -beta and monocyte chemotactic and activating factor utilize common and unique receptors on human monocytes.
    Wang JM; Sherry B; Fivash MJ; Kelvin DJ; Oppenheim JJ
    J Immunol; 1993 Apr; 150(7):3022-9. PubMed ID: 8454871
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Matrix metalloproteinases in human melanoma cell lines and xenografts: increased expression of activated matrix metalloproteinase-2 (MMP-2) correlates with melanoma progression.
    Hofmann UB; Westphal JR; Waas ET; Zendman AJ; Cornelissen IM; Ruiter DJ; van Muijen GN
    Br J Cancer; 1999 Nov; 81(5):774-82. PubMed ID: 10555745
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Human lung macrophages enhance and inhibit lymphocyte proliferation.
    Liu MC; Proud D; Schleimer RP; Plaut M
    J Immunol; 1984 Jun; 132(6):2895-903. PubMed ID: 6609963
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Acquired immune response as a consequence of the macrophage-dependent apoptotic cell clearance and role of the monocyte chemotactic S19 ribosomal protein dimer in this connection.
    Shrestha A; Horino K; Nishiura H; Yamamoto T
    Lab Invest; 1999 Dec; 79(12):1629-42. PubMed ID: 10616212
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibition of macrophage chemotaxis by neoplastic and other rapidly proliferating cells in vitro.
    Normann SJ; Sorkin E
    Cancer Res; 1977 Mar; 37(3):705-11. PubMed ID: 189909
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Chemotactic responses of normal human basophils to C5a and to lymphocyte-derived chemotactic factor.
    Lett-Brown MA; Boetcher DA; Leonard EJ
    J Immunol; 1976 Jul; 117(1):246-52. PubMed ID: 932427
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characteristics of the chemotactic response of neoplastic cells to a factor derived from the fifth component of complement.
    Orr W; Varani J; Ward PA
    Am J Pathol; 1978 Nov; 93(2):405-22. PubMed ID: 568888
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Chemoattractant(s) in culture supernatants of HTLV-I-Infected T-cell lines.
    Saggioro D; Wang JM; Sironi M; Luini W; Mantovani A; Chieco-Bianchi L
    AIDS Res Hum Retroviruses; 1991 Jul; 7(7):571-7. PubMed ID: 1722688
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Investigations about the influence of immune complexes on in vitro migration of human neutrophilic blood granulocytes (author's transl)].
    Blank I
    Allerg Immunol (Leipz); 1978; 24(3):183-90. PubMed ID: 152573
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Human melanoma cell lines differ in their capacity to release ADP and aggregate platelets.
    Boukerche H; Berthier-Vergnes O; Penin F; Tabone E; Lizard G; Bailly M; McGregor JL
    Br J Haematol; 1994 Aug; 87(4):763-72. PubMed ID: 7527241
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Spleen-derived mononuclear cell chemotactic factor in malaria infections: a possible mechanism for splenic macrophage accumulation.
    Wyler DJ; Gallin JI
    J Immunol; 1977 Feb; 118(2):478-84. PubMed ID: 402418
    [No Abstract]   [Full Text] [Related]  

  • 53. Chemotactic and bactericidal capacities of human newborn monocytes.
    Dretschmer RR; Stewardson RB; Papierniak CK; Gotoff SP
    J Immunol; 1976 Oct; 117(4):1303-7. PubMed ID: 977952
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vitro generation of eosinophil chemotactic factor from human and murine mononuclear phagocytes.
    Czarnetzki BM
    Scand J Immunol; 1981; 13(6):511-6. PubMed ID: 6797047
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chemotactic inhibitors in sera of patients with neoplastic disease.
    Mandell LA; Afnan M
    Clin Invest Med; 1991 Apr; 14(2):131-41. PubMed ID: 2060190
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of tumor growth on host defenses.
    Cianciolo GJ; Snyderman R
    Cancer Metastasis Rev; 1986; 5(1):15-27. PubMed ID: 3524888
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Monocyte chemotactic mechanisms in patients with hypernephroma.
    Hemstreet GP; Snyderman R
    Natl Cancer Inst Monogr; 1978 Dec; (49):115-8. PubMed ID: 748765
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Locomotion and chemotaxis of mononuclear phagocytes.
    Wilkinson PC
    Comp Immunol Microbiol Infect Dis; 1985; 8(2):213-24. PubMed ID: 3910344
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Murine malignant cells synthesize a 19,000-dalton protein that is physicochemically and antigenically related to the immunosuppressive retroviral protein, P15E.
    Cianciolo GJ; Lostrom ME; Tam M; Snyderman R
    J Exp Med; 1983 Sep; 158(3):885-900. PubMed ID: 6193238
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Adhesion molecule expression and response to chemotactic agents of human monocyte-derived macrophages.
    Audran R; Lesimple T; Delamaire M; Picot C; Van Damme J; Toujas L
    Clin Exp Immunol; 1996 Jan; 103(1):155-60. PubMed ID: 8565276
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.